Posts by: Carolina Henriques

Carolina Henriques

Carolina holds a BSc in Anthropology and a MSc in Urban Studies., and brings her interdisciplinary skills to her writing on a range of different topics in science, research and advocacy news.

September 15, 2016

Can-Fite’s Patent Application for Psoriasis Therapy Candidate Accepted in Europe

News

Can-Fite BioPharma has received a notice of allowance from the European Patent Office (EPO) accepting the patent application for the company’s new psoriasis treatment Piclidenoson (CF101). Piclidenoson is a novel adenosine ... Read more

September 8, 2016September 8, 2016

Vigorous Regular Exercise Can Lower Risk of Psoriasis, Study Finds

News

The importance of exercise has been emphasized in recent years, as researchers find more and more evidence that physical activity helps to prevent illness and improve general health. These benefits appear to extend to ... Read more

August 17, 2016August 17, 2016

Survey of Psoriasis Patients Highlights Disease’s Emotional Toll, Treatment Challenges

News

A new survey by Health Union, titled “Psoriasis in America 2016,” has revealed that although psoriasis patients agree that a variety of treatment plans are available, they find it difficult to find one that ... Read more

August 5, 2016August 5, 2016

Results of Pivotal Studies Show Taltz Treatment Helped Plaque Psoriasis Patients Be More Productive

News

Results from three, Phase 3 clinical trials showed that patients with moderate-to-severe psoriasis who were treated with Taltz (ixekizumab) reported significant improvements in work productivity over those treated with placebo. The randomized, double-blind, studies were led ... Read more

July 18, 2016July 18, 2016

First Combination Foam Spray for Psoriasis, Enstilar, Now Available in UK

News

Adults with psoriasis who live in the United Kingdom will now have a new treatment option available to manage the disease. LEO Pharma’s Enstilar is the first plaque psoriasis treatment available ... Read more

July 13, 2016

August, Psoriasis Awareness Month, to Bring Weekly ‘Challenges’ and Health Tips

News

This August, Psoriasis Awareness Month, the National Psoriasis Foundation (NPF) will launch a campaign with the twin goals of helping psoriasis patients to take better care of their health and of raising awareness about the 7.5 million ... Read more

June 30, 2016July 1, 2016

Global Psoriasis Survey Shows 85% of US Patients Faced Discrimination

News

Results from the largest global survey on moderate-to-severe psoriasis patients, called Clear About Psoriasis Survey, were released recently by Novartis Pharmacueticals. Comprising 25 groups worldwide, it was the largest collaboration led by ... Read more

May 12, 2016May 19, 2016

Phase 2 Trial of Prurisol for Psoriasis to be Unblinded, Promising Result Expected

News

Cellceutix Corporation recently announced that the clinical database for the phase 2 clinical trial of Prurisol, for treatment of mild-to-moderate chronic plaque psoriasis, will be ‘unblinded’ within the next few ... Read more

May 5, 2016May 5, 2016

Eli Lilly Announces Its Psoriasis Treatment, Taltz, Is Now Available in the US

News

Eli Lilly and Company has announced that Taltz injection 80 mg/mL is now available by prescription order in the U.S. for the treatment of moderate-to-severe plaque psoriasis. Taltz (ixekizumab) was approved ... Read more

May 3, 2016

Largest American Psoriasis Registry to Track Newly Approved Plaque Psoriasis Treatment Ixekizumab

News

The Corrona Psoriasis Registry, a 16-year independent registry with no ownership links to the pharmaceutical industry and the leading sponsor of registries in autoimmune diseases, and the National Psoriasis Foundation ... Read more